Endocrinology

Diabetes management at population scale

Diabetes drives more HEDIS measures than any other single condition: A1c control, retinal exams, nephropathy screening, statin therapy, BP control, and medication adherence. Every one of those measures has a direct financial consequence in value-based contracts. Your endocrinology practice sits at the center of it all.

Glance tracks every diabetic care gap, monitors medication adherence across oral agents and insulin, and gives you population-level analytics to manage hundreds of diabetic patients without losing any individual in the crowd.

Schedule a Demo See Features
Glance — Diabetes Dashboard
Diabetic Population — 847 patients
A1c <7%
38%
A1c 7-8%
29%
A1c 8-9%
18%
A1c >9%
15%
Screening Gaps
Retinal Exam: 214 overdue (25%)
Nephropathy (UACR): 178 overdue (21%)
Statin Therapy: 92 not prescribed (11%)
Oral Med PDC >80%: 634 patients (75%)

Every diabetes measure, one platform

Diabetes care involves more trackable quality measures than any other condition. Glance consolidates all of them into actionable workflows.

A1c Tracking & Care Gaps

Track HbA1c values across your entire diabetic population. See the distribution: how many patients are at goal (<7%), in the HEDIS threshold (<8%), or critically uncontrolled (>9%). Identify patients overdue for testing. Generate outreach lists sorted by A1c level so your team can prioritize the highest-risk patients first.

Medication Adherence (PDC)

Track Proportion of Days Covered for oral diabetes medications (metformin, sulfonylureas, SGLT2i, DPP-4i, GLP-1 agonists), statins, and antihypertensives. Identify patients below the 80% PDC threshold. See fill history gaps and last fill dates. Early intervention on non-adherence prevents the A1c spike you will see three months later.

Retinal Exam Tracking

HEDIS requires annual retinal exams for diabetic patients. Glance tracks which patients have completed their exam (from claims data or clinical documentation), which are overdue, and which have never had one. Generate referral lists for ophthalmology or flag for in-office retinal imaging.

Nephropathy Screening

Track UACR and eGFR for every diabetic patient. Identify those overdue for nephropathy screening, those with abnormal results requiring follow-up, and those with progressive CKD requiring nephrology referral. Reference ranges contextualized for diabetic patients with trending over time.

Diabetes Financial Impact

Diabetes is the most financially consequential condition in VBC. Track the cost of uncontrolled diabetes in your population: ED visits for DKA and hypoglycemia, inpatient admissions, dialysis starts, and amputation procedures. Model the shared savings impact of moving 10 patients from A1c >9% to <8%.

Quality measures driving endocrinology revenue

CDC

A1c Control

HEDIS Comprehensive Diabetes Care — HbA1c testing and control below 8%. The anchor measure for endocrinology.

EYE

Retinal Exam

Annual diabetic retinal exam. One of the most commonly missed care gaps in diabetes management.

KED

Nephropathy

HEDIS Kidney Evaluation for Patients with Diabetes. UACR and eGFR screening and monitoring.

PDC

Med Adherence

Proportion of Days Covered for diabetes medications. Triple-weighted in Medicare Star Ratings.